We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Astec Industries
ASTE
$896M
| $625 | ﹤0.01% |
15
-63
| -81% | -$2.39K |
2025 Q1
1 quarter
|
|
3252
Tempus AI
TEM
$12.9B
| $625 | ﹤0.01% |
10
| – | – |
2025 Q1
1 quarter
|
|
3253
Wave Life Sciences
WVE
$629M
| $618 | ﹤0.01% |
95
| – | – |
2023 Q1
9 quarters
|
|
3254
Sports Entertainment Gaming Global Corp
SEGG
$4.89M
| $610 | ﹤0.01% |
7
| – | – |
2022 Q2
12 quarters
|
|
3255
Solid Biosciences
SLDB
$615M
| $609 | ﹤0.01% |
125
+118
| +1,686% | +$417 |
2022 Q1
13 quarters
|
|
3256
Clearfield
CLFD
$407M
| $608 | ﹤0.01% |
14
| – | – |
2022 Q2
12 quarters
|
|
3257
DELISTED
Select Medical
SEM
| $607 | ﹤0.01% |
40
+32
| +400% | +$499 |
2023 Q4
6 quarters
|
|
3258
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$7.08B
| $602 | ﹤0.01% |
15
-514
| -97% | -$19.8K |
2023 Q2
8 quarters
|
|
3259
Dyne Therapeutics
DYN
$2.86B
| $590 | ﹤0.01% |
62
+35
| +130% | +$385 |
2024 Q2
4 quarters
|
|
3260
Equinox Gold
EQX
$13B
| $581 | ﹤0.01% |
101
-2,600
| -96% | -$16.9K |
2022 Q4
10 quarters
|
|
3261
vTv Therapeutics
VTVT
$109M
| $570 | ﹤0.01% |
38
| – | – |
2020 Q2
20 quarters
|
|
3262
Rapport Therapeutics
RAPP
$1.42B
| $569 | ﹤0.01% |
+50
| New | +$531 |
2025 Q2
0 quarters
|
|
3263
Anterix
ATEX
$1.66B
| $564 | ﹤0.01% |
22
-61
| -73% | -$1.78K |
2020 Q2
20 quarters
|
|
3264
Rocket Pharmaceuticals
RCKT
$259M
| $564 | ﹤0.01% |
230
-802
| -78% | -$4.06K |
2024 Q3
3 quarters
|
|
3265
Enliven Therapeutics
ELVN
$2.88B
| $562 | ﹤0.01% |
28
+18
| +180% | +$341 |
2024 Q4
2 quarters
|
|
3266
Hippo Holdings
HIPO
$930M
| $559 | ﹤0.01% |
20
-75
| -79% | -$1.85K |
2024 Q4
2 quarters
|
|
3267
AFC Gamma
AFCG
$69.7M
| $556 | ﹤0.01% |
124
| – | – |
2022 Q3
11 quarters
|
|
3268
Regenxbio
RGNX
$473M
| $550 | ﹤0.01% |
67
+17
| +34% | +$142 |
2020 Q1
21 quarters
|
|
3269
Distribution Solutions Group
DSGR
$1.62B
| $549 | ﹤0.01% |
20
| – | – |
2022 Q3
11 quarters
|
|
3270
Green Dot
GDOT
$699M
| $547 | ﹤0.01% |
+51
| New | +$461 |
2025 Q2
0 quarters
|
|
3271
NPK International
NPKI
$906M
| $528 | ﹤0.01% |
+62
| New | +$454 |
2025 Q2
0 quarters
|
|
3272
LegalZoom.com
LZ
$1.06B
| $526 | ﹤0.01% |
59
-48
| -45% | -$402 |
2024 Q3
3 quarters
|
|
3273
Patria Investments
PAX
$1.94B
| $506 | ﹤0.01% |
36
-241
| -87% | -$2.89K |
2024 Q4
2 quarters
|
|
3274
Aura Biosciences
AURA
$657M
| $495 | ﹤0.01% |
+79
| New | +$462 |
2025 Q2
0 quarters
|
|
3275
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $493 | ﹤0.01% |
297
-270
| -48% | -$476 |
2025 Q1
1 quarter
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.